Waters Corporation (NYSE:WAT) Director Laurie H. M.D. Glimcher sold 4,800 shares of the stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $175.78, for a total value of $843,744.00. Following the transaction, the director now directly owns 10,849 shares in the company, valued at approximately $1,907,037.22. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Shares of Waters Corporation (WAT) traded down 0.43% during trading on Friday, reaching $184.16. The company’s stock had a trading volume of 611,110 shares. The company has a market cap of $14.74 billion, a PE ratio of 28.00 and a beta of 0.83. Waters Corporation has a 52-week low of $131.35 and a 52-week high of $187.65. The firm’s 50-day moving average is $178.14 and its 200 day moving average is $155.82.

Waters Corporation (NYSE:WAT) last announced its quarterly earnings results on Tuesday, April 25th. The medical instruments supplier reported $1.46 EPS for the quarter, beating the Zacks’ consensus estimate of $1.33 by $0.13. Waters Corporation had a return on equity of 24.30% and a net margin of 24.34%. The company had revenue of $497.97 million during the quarter, compared to analysts’ expectations of $489.37 million. During the same period in the prior year, the company earned $1.26 EPS. Waters Corporation’s revenue was up 4.8% compared to the same quarter last year. On average, equities research analysts predict that Waters Corporation will post $7.32 EPS for the current fiscal year.

Insider Buying and Selling by Quarter for Waters Corporation (NYSE:WAT)

COPYRIGHT VIOLATION WARNING: This piece was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/06/16/waters-co-wat-director-sells-843744-00-in-stock-updated-updated.html.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Advisors Asset Management Inc. boosted its position in shares of Waters Corporation by 9.5% in the third quarter. Advisors Asset Management Inc. now owns 26,203 shares of the medical instruments supplier’s stock worth $4,153,000 after buying an additional 2,276 shares during the last quarter. LMR Partners LLP boosted its position in shares of Waters Corporation by 71.1% in the third quarter. LMR Partners LLP now owns 4,751 shares of the medical instruments supplier’s stock worth $753,000 after buying an additional 1,975 shares during the last quarter. NEXT Financial Group Inc boosted its position in shares of Waters Corporation by 1,428.6% in the third quarter. NEXT Financial Group Inc now owns 1,391 shares of the medical instruments supplier’s stock worth $220,000 after buying an additional 1,300 shares during the last quarter. Columbia Asset Management boosted its position in shares of Waters Corporation by 1.0% in the third quarter. Columbia Asset Management now owns 2,076 shares of the medical instruments supplier’s stock worth $329,000 after buying an additional 20 shares during the last quarter. Finally, Ownership Capital B.V. boosted its position in shares of Waters Corporation by 17.7% in the third quarter. Ownership Capital B.V. now owns 516,798 shares of the medical instruments supplier’s stock worth $81,907,000 after buying an additional 77,628 shares during the last quarter. Institutional investors own 92.34% of the company’s stock.

WAT has been the topic of a number of analyst reports. Zacks Investment Research raised Waters Corporation from a “hold” rating to a “buy” rating and set a $178.00 price objective on the stock in a report on Monday, April 24th. Deutsche Bank AG reissued a “buy” rating and set a $183.00 price objective (up previously from $166.00) on shares of Waters Corporation in a report on Saturday, April 29th. Jefferies Group LLC raised their target price on Waters Corporation from $147.00 to $150.00 and gave the company a “hold” rating in a report on Friday, March 3rd. Janney Montgomery Scott raised Waters Corporation from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $185.00 to $200.00 in a report on Monday, May 1st. Finally, Barclays PLC set a $160.00 price objective on Waters Corporation and gave the stock a “hold” rating in a report on Wednesday, April 26th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $168.91.

About Waters Corporation

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Receive News & Stock Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related stocks with our FREE daily email newsletter.